1. Home
  2. LWLG vs RAPP Comparison

LWLG vs RAPP Comparison

Compare LWLG & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LWLG
  • RAPP
  • Stock Information
  • Founded
  • LWLG 1991
  • RAPP 2022
  • Country
  • LWLG United States
  • RAPP United States
  • Employees
  • LWLG N/A
  • RAPP N/A
  • Industry
  • LWLG Containers/Packaging
  • RAPP
  • Sector
  • LWLG Industrials
  • RAPP
  • Exchange
  • LWLG Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • LWLG 423.3M
  • RAPP 439.4M
  • IPO Year
  • LWLG N/A
  • RAPP 2024
  • Fundamental
  • Price
  • LWLG $3.14
  • RAPP $24.73
  • Analyst Decision
  • LWLG
  • RAPP Strong Buy
  • Analyst Count
  • LWLG 0
  • RAPP 3
  • Target Price
  • LWLG N/A
  • RAPP $34.67
  • AVG Volume (30 Days)
  • LWLG 2.5M
  • RAPP 1.5M
  • Earning Date
  • LWLG 11-12-2025
  • RAPP 11-06-2025
  • Dividend Yield
  • LWLG N/A
  • RAPP N/A
  • EPS Growth
  • LWLG N/A
  • RAPP N/A
  • EPS
  • LWLG N/A
  • RAPP N/A
  • Revenue
  • LWLG $94,355.00
  • RAPP N/A
  • Revenue This Year
  • LWLG N/A
  • RAPP N/A
  • Revenue Next Year
  • LWLG N/A
  • RAPP N/A
  • P/E Ratio
  • LWLG N/A
  • RAPP N/A
  • Revenue Growth
  • LWLG 4.52
  • RAPP N/A
  • 52 Week Low
  • LWLG $0.79
  • RAPP $6.43
  • 52 Week High
  • LWLG $4.23
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • LWLG 58.29
  • RAPP 61.68
  • Support Level
  • LWLG $2.98
  • RAPP $22.06
  • Resistance Level
  • LWLG $3.50
  • RAPP $25.14
  • Average True Range (ATR)
  • LWLG 0.44
  • RAPP 3.15
  • MACD
  • LWLG -0.04
  • RAPP 0.77
  • Stochastic Oscillator
  • LWLG 49.63
  • RAPP 37.71

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: